drugset / Trial / NCT00433693
Correction Study of R744 in Renal Anemia Patients on Hemodialysis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will assess the efficacy and safety of intravenous R744 in renal anemia patients on hemodialysis.
Timeline
- Start
- 2007-02
- Primary completion
- 2008-03
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | methoxy polyethylene glycol-epoetin beta | Protein / enzyme biologic | 25 ug | Intravenous |
| Subject | methoxy polyethylene glycol-epoetin beta | Protein / enzyme biologic | 300 ug | Intravenous |
Indications
No indication recorded.